Estimating Long-Term Survival in the Face of Immature Data: A Case Study of Nivolumab in Second Line Renal Cell Carcinoma
03 medical and health sciences
0302 clinical medicine
DOI:
10.1016/j.jval.2017.08.066
Publication Date:
2017-10-20T10:00:16Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....